Lisa French
EVP & Chief Commercial Officer, Keenova Therapeutics plc.
Companies
- Keenova Therapeutics plcEVP & Chief Commercial Officer Oct 7, 2022 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Keenova Therapeutics plc8,390 shares2Jan 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 1, 2026Shares withheld for tax 1,986 shares of Keenova Therapeutics plc2
- Jan 1, 2026Exercised options 6,576 shares of Keenova Therapeutics plc2
- Jan 1, 2025Shares withheld for tax 1,646 shares of Keenova Therapeutics plc3
- Jan 1, 2025Shares withheld for tax 1,670 shares of Keenova Therapeutics plc4
- Jan 1, 2025Exercised options 5,470 shares of Keenova Therapeutics plc3
- Nov 14, 2023Returned to company 64,455 shares of Keenova Therapeutics plc5
- Oct 1, 2023Shares withheld for tax 10,636 shares at $0.09 of Keenova Therapeutics plc6
- Dec 14, 2022Granted 75,091 shares of Keenova Therapeutics plc7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jan 2, 2025
- 4SEC EDGARForm 4 filed Jan 17, 2025
- 5SEC EDGARForm 4 filed Nov 16, 2023
- 6SEC EDGARForm 4 filed Oct 2, 2023
- 7SEC EDGARForm 4 filed Dec 22, 2022